Delivery of Care
Surviving childhood cancer: how we standardise care across Europe
When Lejla Kameric’s daughter was treated for non-Hodgkin’s lymphoma, the twelve-year-old had to get through lumbar punctures without pain relief. “15 years ago in Bosnia, painful procedures and diagnostic activities were done without anaesthesia,” Kameric recalls. “Still now, young doctors…
Cancer and fertility preservation: it can be done… Can’t it?
“I was 26 when I was diagnosed with Hodgkin lymphoma in 2015. I knew before starting cancer treatment that it is possible to preserve fertility. But having been knocked flat by months of illness and still dazed by the diagnosis,…
Tailored exercise: a key element in personalised treatments and prevention
The expression ‘couch potato’ conjures up images of a worldly-wise, self-mocking type who leaves the rat-race to others, while happily cuddling up in front of the TV with snacks and drinks. Yet the consequences of such a lifestyle are dire.…
Pain relief is a right: building confidence in opioid use in oncology
Opioid analgesics are essential for pain relief and pain treatment in patients with active malignant disease. Yet, in 2011, the World Health Organization estimated that, worldwide, 5.5 million people living with terminal cancer suffered from moderate to severe pain, because…
The oncologist-patients who share their unique insights
“I try not to think about it. However, a few times a day, I have moments of a few seconds when I feel like panic is taking over me. After a while everything passes, but I can't handle it very…
Our pathways: advocates provide roadmaps for patients, clinicians and managers
Patient advocates have a collective understanding of the patient pathway, from the first suspicious symptoms to the realities of life as a survivor, that is unrivalled by any professionals. They also understand better than anyone how valuable that knowledge and…
Immunotherapy toxicities demand a joined up approach from oncologists and organ specialists
Adverse effects of cancer therapies have long been at the root of decision making for interventions in all modalities – surgery, radiotherapy and medical – and especially in the latter category of anti-cancer drugs. Most people have heard of some…
Who wouldn’t want to cure 100% of childhood cancers?
More than eight in ten children and young adults diagnosed with cancer now survive their disease, often going on to live long and fulfilling lives. But the serious life-long damage that is inflicted by many treatments is still a bit…
Berlin pilot project brings precision care to the peripheries
A decade ago, men with metastatic prostate cancer could typically expect to live two to three years. The arrival of new hormone drugs such as abiraterone radically changed the odds, and the equation is now changing every day, as trials…
EMA at 25: learning more from cancer patients
Responsibility for scientific evaluation, supervision and safety monitoring of medicines was done at the national level until 1995, when EU member states agreed to coordinate that work within the European Medicines Agency (EMA). A quarter of a century on, and…